Industry1h ago
Anthropic Launches AI Drug Discovery Program
Anthropic announced June 30, 2026, that it will launch preclinical drug-discovery programs for rare diseases. The company will leverage Claude to identify novel therapeutic targets. This move shifts the firm from a general model provider to a specialized biotech actor. Practitioners should watch for how Anthropic integrates biological data into its core reasoning.